9th Annual Biomarkers Congress
Latest Research at Life Science Meetings
Genome Assisted Biology of Crops and Model Plant Systems Daniel Zilberman, Jian Ye, Huiwen Wu, Esther van der Knaap, Motoaki Seki, Rajani Sarojam, Naoko Nishizawa, Hong Gil Nam, Insuk Lee, Junko Kyozuka, Anna Koltunow, Harry Klee, Masayoshi Kawaguchi, Takeshi Izawa, Dirk Inze, Sanwen Huang, Luis Herrera-Estrella, M. Hasebe, Andrea Eveland, Brian Dilkes, Xiaofeng Cao, Mike Bevan, Thomas Brutnell, Jiayang Li, Robert Martienssen Genome Assisted Biology of Crops and Model Plant Systems April 21, 2014
Insights for Personalized Medicine from the Gut Microbiome Dusko Ehrlich Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Functional Proteomics, Companion Diagnostics and Precise Medicine Peter Parker Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Genomics Medicine Raju Kucherlapati Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
The Future of Academic Research towards Translation for Personalized Medicine Charles L Sawyers Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Integrating Companion Diagnostics in the Healthcare — the Insurance Sector Perspective Michael Kolodziej Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Promoting Personalized Medicine through Policy Strategies Christopher P. Austin Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Towards Biomarker-based Personalized Healthcare: Current Status and Future Trends Mikael Dolsten Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Advances in Blood Pressure Genomics Mark J. Caulfield Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Cardiovascular Disease — Implications for Personalized Medicine Julie A. Johnson Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
mTOR Signaling: a Central Pathway to the Pathogenesis of Multiple Inflammatory and Immune System Disorders — Implications for Personalized Medicine Andras Perl Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Stratified Medicine in Autoimmune Diseases: Rheumatoid Arthritis Examples Iain McInnes Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Industry Spotlight — Development of Kalydeco as a Genotype Specific Drug for the Treatment of Cystic Fibrosis Federico Goodsaid Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Industry Spotlight — Development of Selzentry (Maraviroc) and the Companion Diagnostic HIV Tropism Assay Charles Knirsch Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Case Study: Xalkori Companion Diagnostic Hakan Sakul Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Identification of Biomarkers for the Diagnosis, Prediction, and Progression of Alzheimer's Disease Michelle Mielke Companion Diagnostics: From Biomarker Identification to Market Entry April 28, 2014
Innovation in Metabolomics to Improve Personalized Healthcare Massimo Loda Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
The Impact of Epigenetics on the Future of Personalized Medicine Jane Mellor Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
Sequencing Approaches for Personalized Cancer Therapy Selection Daniela Starcevic Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
Ways to Making Personalized Medicine more Affordable Naomi Aronson Companion Diagnostics: From Biomarker Identification to Market Entry April 29, 2014
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.